A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-039

NCT03502954 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Halted prematurely

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: ABY-039
BIOLOGICAL: Placebo

Sponsor

Affibody

Collaborators

[object Object]